GLYATL2
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
glycine-N-acyltransferase like 2 | MIM:614762 | Ensembl:ENSG00000156689 | HGNC:HGNC:24178 | PA142671728 | 11q12.1 |
GO terms in GLYATL2
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IDA | GO:0047961 | glycine N-acyltransferase activity |
BP | IDA | GO:0042758 | long-chain fatty acid catabolic process |
BP | IDA | GO:0051793 | medium-chain fatty acid catabolic process |
BP | IDA | GO:1903965 | monounsaturated fatty acid catabolic process |
CC | IEA | GO:0005739 | mitochondrion |
CC | IDA | GO:0005783 | endoplasmic reticulum |
Gene expression in normal tissue: GLYATL2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in GLYATL2
Database | Pathway ID | Pathway Des. |
---|---|---|
wikipathways | WP521 | Amino acid conjugation of benzoic acid |
wikipathways | WP702 | Metapathway biotransformation Phase I and II |
reactome | R-HSA-1430728 | Metabolism |
reactome | R-HSA-156580 | Phase II - Conjugation of compounds |
reactome | R-HSA-156587 | Amino Acid conjugation |
reactome | R-HSA-159424 | Conjugation of carboxylic acids |
reactome | R-HSA-177128 | Conjugation of salicylate with glycine |
reactome | R-HSA-177135 | Conjugation of benzoate with glycine |
reactome | R-HSA-211859 | Biological oxidations |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD494 | Neopeltolide | 3 |
iGMDRD781 | Sirolimus | 1 |
iGMDRD387 | CHIR-99021 | 3 |
iGMDRD5 | Tyrphostin AG 1478 | 3 |
iGMDRD138 | PX 12 | 3 |
iGMDRD505 | Pevonedistat | 3 |
iGMDRD506 | Fedratinib | 3 |
iGMDRD780 | PP-30 | 3 |
iGMDRD286 | Nsc 632839 | 1 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in GLYATL2